indirubin-3'-monoxime has been researched along with Carcinoma, Ductal, Pancreatic in 1 studies
indirubin-3'-monoxime: has antiangiogenic activity
indirubin-3'-monoxime : A member of the class of biindoles that is indirubin in which the keto group at position 3' has undergone condensation with hydroxylamine to form the corresponding oxime.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sano, M | 1 |
| Ichimaru, Y | 1 |
| Kurita, M | 1 |
| Hayashi, E | 1 |
| Homma, T | 1 |
| Saito, H | 1 |
| Masuda, S | 1 |
| Nemoto, N | 1 |
| Hemmi, A | 1 |
| Suzuki, T | 1 |
| Miyairi, S | 1 |
| Hao, H | 1 |
1 other study available for indirubin-3'-monoxime and Carcinoma, Ductal, Pancreatic
| Article | Year |
|---|---|
Induction of cell death in pancreatic ductal adenocarcinoma by indirubin 3'-oxime and 5-methoxyindirubin 3'-oxime in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Pancreatic Ductal; CDC2 Protein Kinase; Cell L | 2017 |